Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY (DEFICIT)

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Total Shareholders’ Equity (Deficit)
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Common stock, beginning balance (in shares) at Dec. 31, 2021     62,690,869          
Beginning balance at Dec. 31, 2021 $ 107,222   $ 6   $ 183,024 $ (75,911) $ 103  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation expense 4,411       4,411      
Foreign currency translation, net of tax (128)           (128)  
Net loss (17,293)         (17,293)    
Common stock, ending balance (in shares) at Mar. 31, 2022     62,690,869          
Ending balance at Mar. 31, 2022 $ 94,212   $ 6   187,435 (93,204) (25)  
Common stock, beginning balance (in shares) at Dec. 31, 2022 64,280,631   64,280,631          
Treasury stock, beginning balance (in shares) at Dec. 31, 2022 141,811     141,811        
Beginning balance at Dec. 31, 2022 $ (6,475) $ (6,701) $ 6 $ (381) 198,126 (206,528) 2,076 $ 226
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation expense 1,958 1,958     1,958      
Foreign currency translation, net of tax 418 416         416 2
Net loss $ (7,258) (7,258)       (7,258)    
Common stock, ending balance (in shares) at Mar. 31, 2023 64,280,631   64,280,631          
Treasury stock, ending balance (in shares) at Mar. 31, 2023 141,811     141,811        
Ending balance at Mar. 31, 2023 $ (11,357) $ (11,585) $ 6 $ (381) $ 200,084 $ (213,786) $ 2,492 $ 228